Tubridge™ Granted Green Channel Status for CFDA Approval
Shanghai, China – Tubridge™ Vascular Reconstruction Device ("Tubridge™"), an innovative product of MicroPort NeuroTech (Shanghai) Co ("MicroPort® NeuroTech"), was granted Green Channel status to fast track for China Food and Drug Administration ("CFDA") approval on February 3. This will significantly shorten the approval time, and therefore benefiting more Chinese patients earlier than expected.
Tubridge™ was studied in a prospective, randomized, controlled clinical trial with participation of 12 leading neurovascular intervention centers in China. The results of the trial demonstrated the safety and efficacy of this innovative device in the treatment of large or giant cerebral aneurysms, and were significantly better than the traditional stent-assisted coil embolization technique. The study protocol was published in BMC Neurology, a journal of the prevention, diagnosis and management of neurological disorders.
A cerebral aneurysm is a weak or thin spot on a blood vessel in the brain that balloons up and fills with blood. It is the main cause of subarachnoid hemorrhage. The bulging aneurysm can put pressure on a nerve or surrounding brain tissue. Aneurysms can later burst and bleed into the brain, causing serious complications or even death. Larger aneurysms are the most dangerous, with high aneurysmal rupture rate, high treatment cost, complex operating procedure and high recurrence rate.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.